You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: May 7, 2021

DrugPatentWatch Database Preview

Chartwell Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CHARTWELL, and what generic and branded alternatives to CHARTWELL drugs are available?

CHARTWELL has one hundred and twenty-five approved drugs.

There is one tentative approval on CHARTWELL drugs.

Summary for Chartwell
US Patents:0

Drugs and US Patents for Chartwell

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell TOPIRAMATE topiramate TABLET;ORAL 078410-001 Sep 11, 2013 DISCN No No   Get Started for $10   Get Started for $10
Chartwell Molecules ONDANSETRON ondansetron TABLET, ORALLY DISINTEGRATING;ORAL 077406-004 Dec 26, 2006 DISCN No No   Get Started for $10   Get Started for $10
Chartwell OXAPROZIN oxaprozin TABLET;ORAL 075987-001 Sep 2, 2004 AB RX No No   Get Started for $10   Get Started for $10
Chartwell Rx CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 083922-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10
Chartwell Molecular RAMIPRIL ramipril CAPSULE;ORAL 078745-004 Jun 18, 2008 AB RX No No   Get Started for $10   Get Started for $10
Chartwell Molecules CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 071785-003 Apr 5, 1988 DISCN No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.